>>60514290
Anyone looking to make big bucks

$GALT


They said the 36 month data is on trend with the previous data but they didn't publish, likely rumored due to being in negoitations with a buyer.

the company has the safest and only drug likely to be approved by FDA. 18+ billion peak sales yearly. If its true then it'd skyrocket easily.

they have to publish the data within two weeks.

Examples of buyouts with prices similar to $GALT before the buyout occurred:

Arena Pharmaceuticals (ARNA): ~$1.50 to $100 (2021, Pfizer).
BioClinica (BIOC): ~$0.70 to $12 (2013, JLL Partners).
Dyax Corp (DYAX): ~$1.80 to $37.30 (2015, Shire).
InterMune (ITMN): ~$1.60 to $74 (2014, Roche). Achillion Pharmaceuticals (ACHN): ~$1 to $6 (2020, Alexion buyout).
Endocyte (ECYT): ~$1 to $24 (2018, Novartis buyout).
Pharmacyclics (PCYC): <$1 to $261 (2015, AbbVie buyout).
Trillium Therapeutics (TRIL): $0.23 to $18.50 (2022, Pfizer buyout).
Even BO at $5b we still get 5/0.112 = $45+